An urgent care clinic describes peptides as short amino acid chains that signal cells, with more posts promised this month.
Recap by typeshit. Post by Facebook on Facebook.
The once-daily pill blocks the IL-23 receptor and helped people with moderate to severe ulcerative colitis respond more often than placebo, a new study reports.
Bikman welcomes a new result but argues the likely cause is tirzepatide bringing insulin down rather than the drug slowing aging itself. His view, not a study claim.
Marchione makes the case for pairing GLP-1s with drugs that target amylin, the hormone released after meals that signals fullness to the brain.
Regen says the placebo group saw a 9% drop, while people on retatrutide also lost 31 lb on average and saw systolic blood pressure fall 14 points.
Post hoc REDEFINE 1 data held up in premenopausal, perimenopausal and postmenopausal women, versus low single digits on placebo.
The series sorts the three drugs by how many receptors each one targets, from one to three, and notes retatrutide is still under investigation. Two more peptides are promised.
Loading…